"They gave her something to calm her down": spotting chemical restraint, and what to ask

You find her changed. Drowsy at eleven in the morning, words slurring, her eyes not quite meeting yours. She walks worse. She sleeps in the chair. You ask, and you are told: "She was agitated, the doctor gave her something to calm her down."

That "something" has a name, an order, a reason and — this is the point — a review date. If nobody can give you those, the problem is not the drug. It is that nobody is monitoring it.

1. What chemical restraint means

A drug that treats a symptom is treatment. The same drug given so that a person stays quiet, does not call out, does not get up, does not cause trouble is a restraint — only instead of a belt it is a tablet.

The difference is not the molecule. It is the purpose. And a single question separates them: *what symptom are we treating?* If the answer is "she was agitated in the evening and we are short at night", that is staffing, not medicine.

Said honestly: sometimes a drug is genuinely needed. Delirium, pain that cannot be controlled, distress that makes any care impossible. Nobody here argues that sedation is always wrong. The point is that it must be a documented clinical decision, not an organisational shortcut.

2. The signs something has changed

• she is drowsy during the day, sleeping at times she used to be awake;
• her speech is slurred, she gropes for words more than before;
• she walks worse, sways — and often the falls begin;
• she is not eating, or falls asleep at meals;
• her gaze is blank;
• she is stiff, has tremors, or odd movements of the mouth or tongue — these are effects of antipsychotics and should be reported at once;
• and the simplest sign: a new drug has appeared that nobody explained.

3. The seven questions

In writing, to the Director of Care and the attending physician or nurse practitioner. These are ordinary questions, not an attack.

1. Which drug, what dose, since when?
2. Who ordered it — the attending physician, the NP, a specialist?
3. For which specific symptom? "Agitation" is not a diagnosis.
4. Which reversible causes were ruled out first? (see section 4)
5. Which non-drug approaches were tried, and for how long?
6. When is it reviewed? An antipsychotic in dementia should be reviewed within weeks, not carried for years.
7. Who consented, and on what information?

If more than two answers are vague, you have found the problem.

4. The causes looked for *before* sedating

This is the part that matters most, because sudden agitation in a person with dementia is almost always a symptom, not a personality:

• pain. The commonest cause and the most missed: someone who cannot say "my hip hurts" says it by shouting or hitting. It is looked for with observational pain scales for people who cannot speak;
• a urinary tract infection, which in older adults shows up as confusion before fever;
• constipation, mundane and very common;
• urinary retention;
• dehydration;
• another drug, just started or just stopped;
• hearing and vision: someone who cannot hear or see is frightened;
• the environment: noise, a room change, new staff, late afternoon. A great deal of "evening agitation" is sundowning, and it is handled with light and routine, not a tablet.

The question that covers it: "Before this was started, were pain, urinary infection and constipation ruled out?"

5. Restraining with a drug is restricted by law

This is the part most families do not know. Provincial long-term care legislation does not treat medication as separate from restraint.

In Ontario, the Act is explicit: a resident may not be restrained by the administration of a drug to control the resident, except in the narrow circumstances the law allows — with a physician's order, as a last resort after alternatives, with monitoring and reassessment, and never for staff convenience or as punishment. Other provinces have comparable restrictions and require the least restrictive approach.

The sentence that works: "Is this drug being used to control her behaviour? If so, on whose order, under which policy, with what monitoring, and when is it reassessed?"

6. The number you can look up yourself

Canada publishes it. The proportion of long-term care residents given antipsychotics without a diagnosis of psychosis is a national quality indicator, reported home by home through CIHI, and several provinces publish their own versions.

Look up her home before the meeting. If it sits well above the provincial average, that is not an opinion — it is the home's own reported data, and it changes the conversation entirely.

7. Consent

If she is capable, the decision is hers. If she is not, consent comes from the substitute decision-maker — and in provinces like Ontario the Health Care Consent Act sets a ranked list: guardian, attorney for personal care, then spouse, then child or parent, and so on. The substitute must decide according to her known wishes, not their own preference.

Note too that antipsychotics in dementia are largely an off-label use, with a known increased risk of stroke and death in this population. Not never — but lowest dose, shortest time, planned review.

8. What to ask for concretely

• the medication administration record and access to the chart through the substitute decision-maker;
• a full medication review — pharmacist-led reviews are funded in long-term care. How many drugs in total? Benzodiazepines sharply raise the risk of falls;
• that it goes in the plan of care, with a goal and a review date;
• a gradual dose reduction trial, if the drug has run for months unreviewed. Tapered, never stopped abruptly.

9. If the answers do not come

In order, in writing

1. the Director of Care and the Administrator, with dates and drug names;
2. the attending physician or nurse practitioner;
3. the Family Council, if others are seeing the same thing;
4. the provincial long-term care complaints or reporting line, which can trigger an unannounced inspection.

One objective fact outweighs any argument: if the falls increased after the drug was started, put that in writing. The questions to ask after a fall are here: she fell in the long-term care home.

10. When it is the wrong home

A home that can tell you drug, reason, alternatives tried and review date is doing its job, even if you dislike the answer. One that says "she was agitated" and changes the subject is not.

Curalune Care Help (CA$99) puts together, usually within 24 business hours, a shortlist of 3 to 5 homes matched to her area and care needs — with contacts and the questions to ask about memory care, night staffing and antipsychotic use.

*General information, not medical advice. No medication should be changed or stopped without the clinician caring for the person.*